BibbInstruments AB (FRA:V0R) Debt-to-Equity: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:V0R BibbInstruments AB FRA:V0R
23 GF Score
Price €0.04
! 2 Warning Signs
View Full Analysis

What is BibbInstruments AB Debt-to-Equity?

BibbInstruments AB FRA:V0R -16.23% 23 Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus rates FRA:V0R with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 699 Medical Devices & Instruments companies, BibbInstruments AB ranks worse than 143061.37% on this metric.

BibbInstruments AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €0.00 Mil. BibbInstruments AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €0.00 Mil. BibbInstruments AB's Total Stockholders Equity for the quarter that ended in Mar. 2026 was €3.05 Mil. BibbInstruments AB's debt to equity for the quarter that ended in Mar. 2026 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BibbInstruments AB's Debt-to-Equity or its related term are showing as below:

FRA:V0R's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.23
* Ranked among companies with meaningful Debt-to-Equity only.

BibbInstruments AB  (FRA:V0R) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

BibbInstruments AB Debt-to-Equity Related Terms

BibbInstruments AB Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for BibbInstruments AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BibbInstruments AB Debt-to-Equity Chart

BibbInstruments AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BibbInstruments AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:V0R vs ABT, SYK, MDT: Debt-to-Equity Comparison

For the Medical Devices subindustry, BibbInstruments AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BibbInstruments AB Debt-to-Equity vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BibbInstruments AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BibbInstruments AB's Debt-to-Equity falls into.


FRA:V0R
23GF Score
BibbInstruments AB FRA:V0R
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BibbInstruments AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BibbInstruments AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 3.458
=0.00

BibbInstruments AB's Debt to Equity Ratio for the quarter that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 3.049
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
BibbInstruments AB (FRA:V0R) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BibbInstruments AB and its competitors. According to the industry distribution chart, BibbInstruments AB ranks #999999 out of 699 companies in the Medical Devices & Instruments industry.
Is BibbInstruments AB's Debt-to-Equity too high?
BibbInstruments AB's current Debt-to-Equity is 0.00. Based on the distribution chart, BibbInstruments AB ranks #999999 out of 699 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, BibbInstruments AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does BibbInstruments AB's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BibbInstruments AB ranks #999999 out of 699 companies for Debt-to-Equity. This places BibbInstruments AB in the lower half of its industry. The industry median Debt-to-Equity is 0.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BibbInstruments AB and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BibbInstruments AB's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BibbInstruments AB stock overvalued right now?
BibbInstruments AB (FRA:V0R) has a current Debt-to-Equity of 0.00. The current Debt-to-Equity is 0.00. BibbInstruments AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For BibbInstruments AB (FRA:V0R), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BibbInstruments AB Business Description

Other Exchanges BIBB:Sweden
Address Scheelevagen 2, Medicon Village, Lund, SWE, SE-223 81
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
23GF Score

Get the complete analysis for FRA:V0R

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.04
Price